Krishna Raghunathan, CFO of Supriya Lifescience Ltd, believes that India is well-positioned to meet the growing demands of informed customers, thanks to its access to advanced technology, skilled workforce, and stable business environment. He is confident that these factors will drive the continued growth and global leadership of the Indian pharmaceutical industry.